Brief: Bone Therapeutics SA Announces Final Results From Phase I/IIa Study
Sept 14 (Reuters) - BONE THERAPEUTICS SA BOTHE.BR :
* REG-BONE THERAPEUTICS SA ANNOUNCES FINAL RESULTS FROM
PHASE
I/IIA ALLOB DELAYED-UNION FRACTURE STUDY
* ALL PATIENTS MET PRIMARY ENDPOINT
* OPTIMIZED PRODUCTION PROCESS DELIVERING CRITICAL
IMPROVEMENTS
FOR FUTURE COMMERCIAL USE TO BE APPLIED TO ALL ALLOGENEIC
PLATFORM CLINICAL TRIALS
Source text for Eikon: ID:nGNE4mlwj5
Further company coverage: BOTHE.BR
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Biosenic SA
See all newsBrief: Biosenic Says Enterprise Court Of Nivelles Approves Co's Restructuring Plan
Brief: Biosenic Anticipates Having Sufficient Cash To Carry Out Its Business Objectives Until Q3 2024
Brief: BioSenic Patent Granted In Canada For Broader Protection Of ATO Therapeutic Platform
Brief: Biosenic Files For Additional Patent Protection For Osteoarthritis Drug
Brief: BioSenic Signs New Binding Term Sheet With Phebra PTY Ltd